Eris Lifesciences Limited (ERIS NSE) stock market data APIs
INR1583.253
19.28(1.2%)
as of November 6, 2025
Try our APIs with
free plan!
Eris Lifesciences Limited Financial Data Overview
Price chart is built with
Anychart
Eris Lifesciences Limited, together with its subsidiaries, provides domestic branded formulations for chronic and sub-chronic therapies in India and internationally. The company offers various branded formulations in various therapeutic areas, such as anti"diabetes, cardiovascular, nutrition, dermatology, neuroscience, gynecology, nephrology, and oncology, as well as central nervous system, women's health, and vitamins/minerals/nutrients. It also provides patient care services, including ambulatory blood pressure measurement, ambulatory electrocardiogram measurement, continuous glucose monitoring system, sleep study, and anti-natal care solutions. It offers its products through wholesale drug distributors, stockists, retail and e-commerce pharmacies. Eris Lifesciences Limited was incorporated in 2007 and is headquartered in Ahmedabad, India.
Prev. Close
1583.253
Open
1602.5362
High
1625.3225
Low
1568.9545
52 wk Range
1097.2-1910
Market Cap
215 953 M
P/E Ratio
56.0807
Shares Outstanding
136 M
Revenue
29 352 M
Dividends (Yield)
0
Beta
-0.09
* We provide hundreds of fields of fundamental data, including EBITDA, P/E ratio, PEG ratio, trailing P/E, shareholders, insider transactions, technical metrics, dividends, splits, earnings, and more. Check out our Fundamental Data API.
ETFs with Eris Lifesciences Limited (top by weight)
Ticker
100-day Price Change
Weight
* We provide detailed information about ETF constituents through our Fundamentals API for ETFs. Read the documentation to learn more.
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Eris Lifesciences Limited data using free add-ons & libraries
Get Eris Lifesciences Limited Fundamental Data
Eris Lifesciences Limited Fundamental data includes:
- Net Revenue: 29 352 M
- EBITDA: 10 702 M
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-10-23
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Eris Lifesciences Limited News
New
India's Eris buys nine dermatology brands from Dr. Reddy's for $33 million
BENGALURU (Reuters) -Indian drugmaker Eris Lifesciences Ltd said on Thursday it bought nine dermatology brands from Dr. Reddy's Laboratories Ltd in a 2.75 billion rupees ($33.2 million) deal to expand...
Edited Transcript of ERIS.NS earnings conference call or presentation 2-Jun-20 11:30am GMT
Q4 2020 Eris Lifesciences Ltd Earnings Call AHMEDABAD Jul 18, 2020 (Thomson StreetEvents) -- Edited Transcript of Eris Lifesciences Ltd earnings conference call or presentation Tuesday, June 2, 2020 a...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
